Physician profile
Eric D Manheimer
NPI 1134368608
$4,707.56
in general payments reported to CMS, 2019-2025
8 companies · $776 in 2025
The $776 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $367 · 2020: $296 · 2021: $918 · 2022: $681 · 2023: $1,090 · 2024: $580 · 2025: $776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,445.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,037.21 | 2019-2025 | General - Therapies, Resonate El Icd Vr, Farapulse |
| Biosense Webster, INC. | $1,724.15 | 2020-2025 | Carto 3, Nuvision Ice Catheter, Qdot Micro |
| Medtronic, INC. | $765.44 | 2021-2025 | Corevalve Evolut R, Aurora Ev-Icd Mri Surescan, Micra |
| Abbott Laboratories | $109.17 | 2021 | |
| Cardiovascular Systems INC. | $22.67 | 2022 | |
| Sanofi-Aventis U.S. LLC | $20.27 | 2023 | |
| Cordis US Corp. | $15.35 | 2025 | Mynx Control Venous |
| Astrazeneca Pharmaceuticals LP | $13.30 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Manheimer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.